Historical record - last NADAC publication: 11/18/2020
Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1237 per EA under NDC 68382003406. Its NADAC has been published 367 times since Nov 28, 2013.
Strength
37.5 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382003406
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
11/18/2020
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090174On Market Since
6/1/2011
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 367 times since Nov 28, 2013, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1237 per EA |
|---|---|
| All-time high | $0.2892 (Mar 12, 2014) |
| All-time low | $0.1170 (Apr 17, 2019) |
| Median price | $0.1402 |
| Average price | $0.1446 |
| Largest weekly change | +52.8% (Feb 19, 2014) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1237 per EA (NDC 68382003406), effective Dec 2, 2020.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 16.6%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.1170 (Apr 17, 2019) to a high of $0.2892 (Mar 12, 2014), with a median of $0.1402 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0795 per EA — about 36% below VENLAFAXINE HCL ER 37.5 MG CAP.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 68382003406) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification